Triple Helix Discovery Engine
Regional Innovation Cluster Strategy & Analytics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
Delfi Diagnostics

Finance & Acquisitions: Delfi Diagnostics

Parents

2021: $100 million series A led by Orbimed Advisors LLC, Menlo Ventures, Samsara Biocapital, Illumina Ventures, Av8 Ventures, Foresite Capital, Northpond Ventures, Cowen Healthcare Investments and Rock Springs Capital.
2021: Delfi Diagnostics reels in $100M for blood-based cancer test
2022: Delfi Diagnostics Raises $225M in Series B Financing
2022: Raised $225 million in a Series B financing, led by DFJ Growth with participation from Eli Lilly, Point72, Brown Advisory, Point Field Partners, Initiate Ventures, Open Field Capital, PTX Capital, Cowen Healthcare Investments, Foresite Capital, Menlo Ventures, OrbiMed, funds and accounts advised by T. Rowe Price Associates, Northpond Ventures, Samsara BioCapital, Rock Springs Capital, AV8 Ventures, Illumina Ventures, Osage University Partners, and Windham Venture Partners.
Delfi’s $100 million series A round was led by OrbiMed with additional backing from Foresite Capital, Northpond Ventures, Cowen Healthcare Investments, Rock Springs Capital, T. Rowe Price Associates, Menlo Ventures, Samsara Biocapital, Illumina Ventures, AV8 Ventures and Windham Venture Partners.